Doctor profile · Federal record

Dr. Gineth Pinto-Patarroyo, MD

Rheumatology Physician (CMS: Rheumatology) · Manassas, VA

  • NPI 1962657411
  • Accepts Medicare
  • 26 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8100 Ashton Ave Ste 215
Manassas, VA 201095688
(703) 361-3255
fax (703) 361-6990
Mailing address
13584 Big Boulder RD
Herndon, VA 201715000

Credentials & registration

NPPES · NUCC
NPI registered
November 2008 — 18 yrs on file
Profile last updated
March 5, 2019
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Virginia #0101263192

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1962657411. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
52,777
Distinct HCPCS
10
Medicare allowed
$394,605
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 49,600 23 $5
J0897 Injection, denosumab, 1 mg 1,680 19 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 363 121 $140
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 306 50 $86
J2405 Injection, ondansetron hydrochloride, per 1 mg 288 11 $0
96413 Administration of chemotherapy into vein, 1 hour or less 153 30 $156
96375 Injection of additional new drug or substance into vein 73 16 $18
96415 Administration of chemotherapy into vein, each additional hour 63 11 $32
J1885 Injection, ketorolac tromethamine, per 15 mg 56 17 $1
96372 Injection of drug or substance under skin or into muscle 39 21 $15

In context: peer comparison

Among 3 peers in this city , average services per provider: 5,923. This provider delivers 8.9× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,810
Transactions
121
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 11 $352.85
Amgen Inc. 12 $302.50
Novartis Pharmaceuticals Corporation 13 $292.78
UCB, Inc. 14 $278.72
ANI Pharmaceuticals, Inc. 15 $252.43
Mallinckrodt Hospital Products Inc. 7 $199.67
ABBVIE INC. 8 $159.29
E.R. Squibb & Sons, L.L.C. 7 $144.04
PFIZER INC. 14 $133.35
AstraZeneca Pharmaceuticals LP 5 $122.53
Fresenius Kabi USA, LLC 4 $103.51
GlaxoSmithKline, LLC. 3 $85.85
Lilly USA, LLC 3 $69.08
Alexion Pharmaceuticals, Inc. 2 $54.52
Sandoz Inc. 3 $50.57

By nature of payment

Food and Beverage
$2,697
Education
$113

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
549
Patients
94
Total drug cost
$891,025
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 124 35 $7,263
Methotrexate (Methotrexate Sodium) Brand 60 20 $1,591
Gabapentin Generic 55 0 $425
Prednisone Generic 47 17 $492
Xeljanz Xr (Tofacitinib Citrate) Brand 44 0 $286,732
Rinvoq (Upadacitinib) Brand 36 0 $233,244
Pregabalin Generic 31 0 $256
Folic Acid Generic 25 11 $124
Celecoxib Generic 24 0 $1,713
Methylprednisolone Generic 20 11 $690

Frequently asked questions

Auto-generated from federal data
What is Dr. Gineth Pinto-Patarroyo's medical specialty?
Dr. Gineth Pinto-Patarroyo practices Rheumatology Physician in Manassas, VA.
Where does Dr. Gineth Pinto-Patarroyo practice?
Dr. Gineth Pinto-Patarroyo practices at 8100 Ashton Ave Ste 215, Manassas, VA 201095688. Office phone: 7033613255.
What is Dr. Gineth Pinto-Patarroyo's NPI?
Dr. Gineth Pinto-Patarroyo's National Provider Identifier (NPI) is 1962657411, issued by NPPES.
Does Dr. Gineth Pinto-Patarroyo accept Medicare assignment?
Yes. Dr. Gineth Pinto-Patarroyo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gineth Pinto-Patarroyo commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.